An anti-β-glucan monoclonal antibody (mAb 2G8) was protective in animal models of invasive mycoses (Rachini et al., 2007), consistent with the protection afforded by a β-glucan vaccine (Torosantucci et al., 2005). Here, PPIB is linked to fungal infectious disease.